2020
Childhood cancer epidemiology in the Czech Republic (1994–2016)
KREJČÍ, Denisa, Michaela ZAPLETALOVÁ, Ivana KATINOVÁ, Viera BAJČIOVÁ, Peter MÚDRY et. al.Základní údaje
Originální název
Childhood cancer epidemiology in the Czech Republic (1994–2016)
Autoři
KREJČÍ, Denisa (203 Česká republika, garant, domácí), Michaela ZAPLETALOVÁ (203 Česká republika), Ivana KATINOVÁ (203 Česká republika, domácí), Viera BAJČIOVÁ (703 Slovensko, domácí), Peter MÚDRY (203 Česká republika, domácí), Vratislav ŠMELHAUS (203 Česká republika), Jaroslav ŠTĚRBA (203 Česká republika, domácí), Jan STARÝ (203 Česká republika), Riccardo CAPOCACCIA (380 Itálie) a Ladislav DUŠEK (203 Česká republika, domácí)
Vydání
Cancer Epidemiology, Oxford, Elsevier, 2020, 1877-7821
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.984
Kód RIV
RIV/00216224:14110/20:00117433
Organizační jednotka
Lékařská fakulta
UT WoS
000596559500004
Klíčová slova anglicky
childhood cancer; incidence; mortality; survival; czech republic
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 4. 3. 2021 10:38, Mgr. Tereza Miškechová
Anotace
V originále
Background: The knowledge of cancer burden in the population, its time trends and the possibility of international comparison is an important starting point for cancer control programmes. Our study aimed to evaluate trends in childhood cancer epidemiology of patients aged 0–14 years in the period 1994–2016 in the Czech Republic. Methods: Data on childhood cancers have been obtained from the Czech National Cancer Registry. These data were validated using the clinical database of childhood cancer patients and combined with data from death certificates. Incidence and mortality trends were assessed by the joinpoint regression method. The life tables method was used to calculate the overall age-standardised five-year survival. Results: The incidence trend was stable; the age-standardised (world) cancer incidence – ASR (W) – was 173.7 per 1 million children in the period 1994–2016. However, there was apparent significant decrease in mortality: ASR (W) dropped from 58.1 per 1 million children in 1994 to 21.4 per 1 million children in 2016. The overall fiveyear survival increased over time by 10 %. Statistically significant improvements in survival were observed in patients with lymphoid leukaemia, astrocytomas, neuroblastomas, osteosarcomas and rhabdomyosarcomas. Conclusion: Such a relevant increase in survival rates, and therefore also a decrease in mortality rates in the Czech Republic, is most likely due to improvements in diagnostic and treatment methods since the 1990s, which were facilitated by the concentration of childhood cancer patients in children’s cancer centres.
Návaznosti
MUNI/A/1409/2019, interní kód MU |
|